Benjamin Burnett
Stock Analyst at Wells Fargo
(0.14)
# 4,677
Out of 5,043 analysts
436
Total ratings
34.9%
Success rate
-6.5%
Average return
Main Sectors:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Downgraded: Hold | $108 → $30 | $27.99 | +7.18% | 11 | Oct 2, 2026 | |
| AXSM Axsome Therapeutics | Rated: Buy | $256 | $182.07 | +40.61% | 11 | Oct 1, 2026 | |
| TECX Tectonic Therapeutic | Rated: Buy | $93 | $22.67 | +310.23% | 5 | Sep 29, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Hold | $18 | $14.75 | +22.03% | 12 | Sep 18, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $69 → $64 | $38.93 | +64.40% | 13 | Sep 18, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $14 | $3.88 | +260.82% | 10 | Sep 9, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $20 | $25.35 | -21.10% | 3 | Sep 2, 2026 | |
| KROS Keros Therapeutics | Reiterated: Buy | $18 | $11.26 | +59.86% | 6 | Sep 2, 2026 | |
| MNKD MannKind | Reiterated: Buy | $13 | $3.95 | +229.11% | 9 | Sep 2, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $109 | $64.13 | +69.97% | 9 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $700 | $571.38 | +22.51% | 12 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $11.95 | +8.79% | 3 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 | $37.60 | +91.49% | 3 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $22.86 | +92.48% | 2 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $9 | $5.05 | +78.39% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $323 → $362 | $286.91 | +26.17% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $161 → $169 | $108.59 | +55.63% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $40.54 | +60.34% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $32.83 | +40.12% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $64 | $205.89 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $13 | $1.89 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $8.21 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $4 | $1.54 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $14.23 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $8.46 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $2.30 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $92 | $63.61 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $0.598 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $49 | $55.44 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $64 | $37.81 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.0002 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $6.33 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.9 → $3.6 | $0.1453 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.7 → $3 | $46.99 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $26.55 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.0001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $24.39 | n/a | 2 | Feb 28, 2022 |
Liquidia
Oct 2, 2026
Downgraded: Hold
Price Target: $108 → $30
Current: $27.99
Upside: +7.18%
Axsome Therapeutics
Oct 1, 2026
Rated: Buy
Price Target: $256
Current: $182.07
Upside: +40.61%
Tectonic Therapeutic
Sep 29, 2026
Rated: Buy
Price Target: $93
Current: $22.67
Upside: +310.23%
Ultragenyx Pharmaceutical
Sep 18, 2026
Rated: Hold
Price Target: $18
Current: $14.75
Upside: +22.03%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $69 → $64
Current: $38.93
Upside: +64.40%
Wave Life Sciences
Sep 9, 2026
Reiterated: Buy
Price Target: $14
Current: $3.88
Upside: +260.82%
Amphastar Pharmaceuticals
Sep 2, 2026
Reiterated: Hold
Price Target: $20
Current: $25.35
Upside: -21.10%
Keros Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $18
Current: $11.26
Upside: +59.86%
MannKind
Sep 2, 2026
Reiterated: Buy
Price Target: $13
Current: $3.95
Upside: +229.11%
PTC Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $109
Current: $64.13
Upside: +69.97%
Sep 2, 2026
Reiterated: Buy
Price Target: $700
Current: $571.38
Upside: +22.51%
Aug 31, 2026
Reiterated: Hold
Price Target: $13
Current: $11.95
Upside: +8.79%
Aug 31, 2026
Reiterated: Buy
Price Target: $72
Current: $37.60
Upside: +91.49%
Aug 31, 2026
Reiterated: Buy
Price Target: $44
Current: $22.86
Upside: +92.48%
Aug 11, 2026
Rated: Buy
Price Target: $9
Current: $5.05
Upside: +78.39%
Aug 7, 2026
Reiterated: Hold
Price Target: $323 → $362
Current: $286.91
Upside: +26.17%
Aug 6, 2026
Reiterated: Buy
Price Target: $161 → $169
Current: $108.59
Upside: +55.63%
Jul 29, 2026
Rated: Buy
Price Target: $65
Current: $40.54
Upside: +60.34%
Apr 22, 2026
Reiterated: Buy
Price Target: $46
Current: $32.83
Upside: +40.12%
Apr 1, 2025
Reiterated: Buy
Price Target: $78 → $64
Current: $205.89
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $26 → $13
Current: $1.89
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $8.21
Upside: n/a
Mar 17, 2025
Reiterated: Hold
Price Target: $4.5 → $4
Current: $1.54
Upside: n/a
Mar 17, 2025
Reiterated: Buy
Price Target: $18
Current: $14.23
Upside: n/a
Mar 11, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $8.46
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $2.30
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $94 → $92
Current: $63.61
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $80
Current: $0.598
Upside: n/a
Feb 13, 2025
Reiterated: Hold
Price Target: $53 → $49
Current: $55.44
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $66 → $64
Current: $37.81
Upside: n/a
Apr 19, 2024
Reiterated: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 16, 2023
Reiterated: Buy
Price Target: $42
Current: $6.33
Upside: n/a
Aug 10, 2023
Reiterated: Hold
Price Target: $3.9 → $3.6
Current: $0.1453
Upside: n/a
Mar 2, 2023
Reiterated: Hold
Price Target: $4.7 → $3
Current: $46.99
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $26.55
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.0001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $24.39
Upside: n/a